Fujifilm Hldgs Corp (FUJIY) 38.6500 $FUJIY
Healthcare IT Market in UAE 2015-2019 - The Analysts Forecast the Market in UAE to Grow at a CAGR of 11.12% During 2014-2019
M2 - Wed Aug 19, 8:42AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hgmn7v/healthcare_it) has announced the addition of the "Healthcare IT Market in UAE 2015-2019" report to their offering. The analysts forecast the healthcare IT market in UAE to grow at a CAGR of 11.12% during 2014-2019. Covered in this Report This report covers the present scenario and the growth prospects of the healthcare IT market in UAE for 2015-2019. The market in UAE is categorized into three segments: hardware, software, and IT services. The report, Healthcare IT Market in UAE 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It covers the market landscape and its growth prospects in the coming years. The report also includes the profile of key vendors operating in this market. A major trend observed in this market is the adoption of patient registry software. Patient registry software is used to maintain a database for collecting secondary data related to patients. It provides timely and effective medical care by allowing physicians and staff to analyze patients' health, diagnosis, and treatment records. According to the report, the increasing government support for healthcare IT systems in this region is a driver that promotes growth in this market. Government initiatives and efforts to manage and streamline healthcare systems through IT have led to increased demand for IT products and services in the healthcare sector. Key Vendors - Cerner - GE Healthcare - HP - IBM - OCSHI - Siemen Other Prominent Vendors - Accenture - Agfa-Gevaert - Anglo Arabian Healthcare - Atos Healthcare - Balaxi Healthcare - Carestream Health - CGM - Ciber - Cisco Systems - Cognizant - CSC - Datasel Healthcare IT Solutions FZ - Eclinicalworks - FUJIFILM Holdings - Harris - Heathland - iSoft - Microsoft - Netcetera - Nuviun - Philips Healthcare - Sunquest Information Systems - Wipro Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Market Segmentation by Category 08. Buying Criteria 09. Market Growth Drivers 10. Drivers and their Impact 11. Market Challenges 12. Impact of Drivers and Challenges 13. Market Trends 14. Trends and their Impact 15. Vendor Landscape 16. Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/hg...lthcare_it
WIT: 12.80 (+0.22), IBM: 152.39 (+0.11), CERN: 64.08 (+0.66)
When Others Try to Disrupt, They Adjust
at The Street - Fri Aug 07, 2:30PM CDT
Some companies have been able to survive and thrive in new environments.
PBI: 20.81 (-0.04), KODK: 16.33 (-0.12), BBRY: 7.41 (+0.12), MSFT: 47.11 (-0.34), FLWS: 9.89 (-0.21), AAPL: 112.12 (+2.62), NOK: 6.98 (-0.06)
Fujifilm (FUJIY) Reports Strong Q1; Earnings Improve Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jul 31, 9:54AM CDT
Premium photographic image-product company Fujifilm Holdings Corporation (FUJIY) reported strong first-quarter fiscal 2016 (ended Jun 30, 2015) results.
ANY: 3.05 (-0.16), CRUS: 28.84 (-0.42), MLNX: 44.19 (+0.14)
Fujifilm (FUJIY) Retains Scope for Growth Despite Risks - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 13, 3:10PM CDT
We have issued an updated research report on the premium multinational company FUJIFILM Holdings Corporation (FUJIY) on Jul 10, 2015.
PLAB: 9.39 (-0.08), ANY: 3.05 (-0.16), ARMH: 43.99 (-0.22)
Global Market Study on Diagnostic Imaging Devices: Asia-Pacific to Witness Highest Growth by 2020
M2 - Wed Jul 08, 8:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2qh8mq/global_market) has announced the addition of the "Global Market Study on Diagnostic Imaging Devices: Asia-Pacific to Witness Highest Growth by 2020" report to their offering. The global diagnostic imaging devices market is anticipated to grow from an estimated USD 26,477.1 million in 2014 to USD 35,793.4 million in 2020 at a CAGR of 5.2% during the forecast period. Globally, the diagnostic imaging devices market is witnessing significant growth due to increasing prevalence of chronic diseases and injuries, and growing aging population. In addition, increasing funding from government bodies, rising initiatives undertaken by government associations to boost awareness, technological advancement and widening application of diagnostic imaging devices are also fueling the growth of the market. However, strict regulatory requirements and heightened risk of cancer owing to exposure to radiation restrain the growth of the global diagnostic imaging devices market. North America is the largest market for diagnostic imaging devices while X-rays are the most popular type of diagnostic imaging devices. In terms of growth, Asia is the fastest growing region; while nuclear imaging and computed tomography scanners make for the fastest growing type of diagnostic imaging devices. Ultrasound is a widely used imaging modality used for diagnosis, staging various diseases and to study internal body structures such as soft tissues and internal organs. The global ultrasound diagnostic imaging devices market was expected to grow from an estimated USD 6,146.7 million in 2014 to USD 8,363.4 million in 2020 at a CAGR of 5.3% during the forecast period. Key Topics Covered: Chapter 1 Preface Chapter 2 Market Synopsis Chapter 3 Porter's Five Forces Analysis Chapter 4 Industry Overview Chapter 5 Global Market Size and Forecast Chapter 6 Market Size and Forecast by X-rays Chapter 7 Market Size and Forecast by Ultrasound Chapter 8 Market Size and Forecast by Computed Tomography Chapter 9 Market Size and Forecast by Magnetic Resonance imaging Chapter 10 Market Size and Forecast by Nuclear Imaging Chapter 11 Market Size and Forecast by Geography Chapter 12 Competitive Scenario Chapter 13 Company Profiles - Carestream Health, Inc. - FUJIFILM Holdings Corporation - General Electric Company - Hitachi, Ltd. - Hologic, Inc. - Koninklijke Philips N.V. - Samsung Electronics Co., Ltd. - Shimadzu Corporation - Siemens Healthcare - Toshiba Corporation For more information visit http://www.researchandmarkets.com/research/2q...bal_market
GE: 28.07 (+0.04), HOLX: 37.28 (+0.08)
Europe Departmental Picture Archiving and Communication System Market by Product (Radiology PACS, Cardiology PACS, Others), by Deployment) & End User (Hospitals, Laboratories, Physicians) 2015-2019
M2 - Thu Jun 25, 8:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2v75f9/europe) has announced the addition of the "Europe Departmental Picture Archiving and Communication System (PACS) Market by Product, by Deployment, by End User And By Component - Analysis and Forecast to 2019" report to their offering. Europe represents the second largest market for Departmental PACS and in future it is expected to grow at a CAGR of 5.2% from 2014 to 2019. Germany commands the largest share of 25.1% of the European Departmental PACS, followed by France. Factors such as the growing trend of public healthcare systems and high price contracts, hospital consolidation, rising number of cardiology disorders, and technological advancements in cardiac monitoring facilities mainly drive the growth of the European Departmental PACS Market. However, factors such as creation of data silos, interoperability and hardware compatibility issues, expensive technology, and a compulsory need of professional assistance further limit the growth of this market. The report provides a DeepDive analysis of major market segments which include applications, deployment, component, types, end-users, and geography. The application segment comprises computed tomography, ultrasound, MRI, C-arms, digital radiography, nuclear imaging, and computed radiography. Deployments are divided on the basis of web-based, on-premise, and cloud based. Similarly, based on components, the market is classified into services, software, and hardware. The departmental PACS market is divided into two types-radiology and cardiology PACS. The key market players of the European Departmental PACS market include Agfa-Gevaert Group. (Belgium), Koninklijke Philips N.V. (Netherlands), Carestream Health (U.S.), FUJIFILM Holdings Corporation (Japan), McKesson Corporation (U.S.), General Electric Company (U.S.), and Siemens AG (Germany). For more information visit http://www.researchandmarkets.com/research/2v75f9/europe
GE: 28.07 (+0.04), MCK: 189.95 (+3.66)
The Global Flexible Endoscopes Market to Grow at a CAGR of 5.99% over the Period 2015-2019
M2 - Mon Jun 15, 4:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2s36m5/global_flexible) has announced the addition of the "Global Flexible Endoscopes Market 2015-2019" report to their offering. The report covers the present scenario and the growth prospects of the global flexible endoscopes market for the period 2015-2019. The market is divided into two segments: flexible videoscopes and flexible fiberscopes. Commenting on the report, an analyst from the research team said: Advances in technology have led to the development of innovative visualization technologies in endoscopes. Manufacturers are now offering a wide range of HD flexible endoscopes that provide high-quality images when used with compatible processors for better diagnosis of diseased organs or areas. HD images can now be combined with video systems that allow a more enhanced look at the mucosal surface of the organ. The system produces a light spectrum that recovers irregularities in the superficial mucosal surface that would not otherwise be detectable with standard white light. According to the report, as a person ages, the incidence of GI diseases such as colorectal and esophageal cancer, pancreatic, biliary, inflammatory bowel, and gastroesophageal reflux diseases, polyps, and other intestinal disorders increases. Many of these diseases are diagnosed or treated using endoscopy. The procedure is safe and effective, especially in elderly patients, and can be performed irrespective of age. Improved living conditions, the quality of healthcare, and advances in treatment options have led to a high demand for endoscopy in healthcare settings, which has increased the life expectancy of the aged. Companies Mentioned: - FUJIFILM Holdings - HOYA - Olympus Medical Systems - Cogentix Medical - KARL STORZ - MACHIDA Endoscope - Optim - Richard Wolf Medical Instruments - Stryker For more information visit http://www.researchandmarkets.com/research/2s...l_flexible About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CGNT: 1.28 (+0.03)
Event - Duodenoscope Panel Could Cut Olympus's Sales
EP Vantage - Seeking Alpha - Mon May 11, 10:45AM CDT
February’s outbreak of device-associated drug-resistant bacterial infections in the US did not prompt a product recall despite several patient deaths. Instead the FDA has responded- three months later- with an adcom, whose recommendations next...
Global Small Animal Imaging (In-Vivo) Market (Technology, Applications and Geography) - Industry Analysis and Forecast, 2013 - 2020
M2 - Fri May 08, 5:09AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w3lm7d/global_small) has announced the addition of the "Global Small Animal Imaging (In-Vivo) Market (Technology, Applications and Geography) - Industry Analysis and Forecast, 2013 - 2020" report to their offering. The market for small animal imaging (In-Vivo) is expected to reach at $2.1 billion by 2020 Rising number of Pharmaceutical companies and clinical research organizations, increasing applications of in-vivo imaging in pre-clinical research, real time data storage and high-resolution modalities, are the key growth factors of the market. Inadequate infrastructure provisions for research facilities, advanced instruments and the lack of skilled research personnel in emerging economies along with the requirement of high-end devices are likely to be the major restraints of small animal imaging (in-vivo) market. Going forward, the global clinical research initiatives, along with the development in technologies associated with pre-clinical trials will provide the platform for growth. North America, dominates the market amongst all geographies owing to adoption of advanced technologies, healthcare awareness and favorable reimbursement policies. Geographically, about -35 of the small animal imaging (in-vivo) market share is held by the North America owing to the heavy investments and affordability of advanced small animal in-vivo imaging devices in pre-clinical research. On the other hand, Asia-Pacific market would grow at the promising CAGR of 11.5% over the forecast period. Such high growth rate is majorly attributed towards untapped state of the market, hence would provide an opportunities for the small animal imaging devices manufacturers. Key Topics Covered: CHAPTER 1 INTRODUCTION CHAPTER 2 EXECUTIVE SUMMARY CHAPTER 3 MARKET OVERVIEW CHAPTER 4 GLOBAL SMALL ANIMAL IMAGING (IN VIVO) MARKET BY TECHNOLOGY CHAPTER 5 GLOBAL SMALL ANIMAL IMAGING (IN VIVO) MARKET BY APPLICATION CHAPTER 6 GLOBAL SMALL ANIMAL IMAGING (IN VIVO) MARKET BY GEOGRAPHY, 2013 2020, $MILLION CHAPTER 7 COMPANY PROFILES - Aspect Imaging Ltd. - Bruker Corporation - FUJIFILM Holdings Corporation - Life Technologies Corporation - Mediso Medical Imaging Systems - Miltenyi Biotech GmbH - PerkinElmer, Inc. - Promega Corporation - Siemens AG - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/w3...obal_small
LIFE: 11.59 (+0.04), PKI: 48.19 (+0.31)
Fujifilm Posts Improved Y/Y Q4 Results, Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue May 05, 10:40AM CDT
Share price of Fujifilm Holdings Corporation (FUJIY) rose 1.7% to close at $38.56 on May 4, 2015, after it reported fourth-quarter fiscal 2015 results on Apr 30.
ANY: 3.05 (-0.16), ALU: 3.74 (-0.04), ARMH: 43.99 (-0.22)
Successful Closure of the TOB for Cellular Dynamics International Inc., a Leading U.S. Company in the Development and Manufacture of iPSCs
Business Wire - Fri May 01, 5:31AM CDT
On April 3, 2015, FUJIFILM Holdings Corporation (President: Mr. Shigehiro Nakajima) (hereafter, "Fujifilm"
launched a tender offer bid (hereafter, "TOB" offering USD 16.50 per share for the issued and outstanding shares of common stock of Cellular Dynamics International, Inc., a leading company in the development and manufacture of iPS Cells (CEO: Robert Palay, Headquarters: Madison, Wisconsin, USA, NASDAQ listed, Securities code: ICEL) (hereafter, "CDI" . The TOB period expired on April 30, 2015 at 11:59 PM (U.S. Eastern Standard Time). The TOB is now successfully completed. On May 1, 2015 (U.S. Eastern Standard Time), following the completion of the necessary procedures, CDI will become a wholly-owned subsidiary of Fujifilm.
WeissLaw LLP: The Cellular Dynamics International Acquisition by FUJIFILM Holdings Corporation Is the Subject of a Legal Investigation
PR Newswire - Fri Apr 03, 10:41AM CDT
The fairness of the proposed acquisition of Cellular Dynamics International ("ICEL" or the "Company" by FUJIFILM Holdings Corporation ("FUJIFILM" is being investigated by WeissLaw LLP, a national class action, shareholder rights law firm. The investigation focuses on possible breaches of fiduciary duty and other violations of law by the Board of Directors of ICEL for agreeing to sell the Company to FUJIFILM. On March 30, 2015, the Company announced a definitive agreement for FUJIFILM to acquire ICEL in a transaction valued at approximately $307 million. Under the terms of the agreement, ICEL shareholders will receive $16.50 in cash for each ICEL share they own.
ICEL: 16.55 (+0.03)
WeissLaw LLP: Cellular Dynamics International Acquisition By FUJIFILM Holdings Corporation May Not Be In The Best Interest of ICEL Shareholders
PR Newswire - Wed Apr 01, 12:05PM CDT
The fairness of the proposed acquisition of Cellular Dynamics International ("ICEL" or the "Company" by FUJIFILM Holdings Corporation ("FUJIFILM" is being investigated by WeissLaw LLP, a national class action, shareholder rights law firm. The investigation focuses on possible breaches of fiduciary duty and other violations of law by the Board of Directors of ICEL for agreeing to sell the Company to FUJIFILM. On March 30, 2015, the Company announced a definitive agreement for FUJIFILM to acquire ICEL in a transaction valued at approximately $307 million. Under the terms of the agreement, ICEL shareholders will receive $16.50 in cash for each ICEL share they own.
ICEL: 16.55 (+0.03)
Ryan & Maniskas, LLP Announces Investigation of Cellular Dynamics International, Inc.
PR Newswire - Wed Apr 01, 9:43AM CDT
Ryan & Maniskas, LLP is investigating potential claims against the board of directors of Cellular Dynamics International, Inc. ("Cellular Dynamics" or the "Company" (NASDAQ: ICEL) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to FUJIFILM Holdings Corporation in a transaction valued at approximately $307 million.
ICEL: 16.55 (+0.03)
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Cellular Dynamics International, Inc. - ICEL
PR Newswire - Tue Mar 31, 9:10PM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Cellular Dynamics International, Inc. ("Cellular Dynamics" or "the Company" (Nasdaq: ICEL) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to FUJIFILM Holdings Corporation. ("FUJIFILM" .
ICEL: 16.55 (+0.03)
CELLULAR DYNAMICS INTERNATIONAL, INC. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Merger with FUJIFILM Holdings Corporation
Business Wire - Tue Mar 31, 10:06AM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Cellular Dynamics International, Inc. ("Cellular Dynamics" (NASDAQ: ICEL) concerning the merger with FUJIFILM Holdings Corporation. Under the terms of the agreement, valued at approximately $307 million, Cellular Dynamics shareholders will only receive $16.50 cash per share held, which is virtually no premium over the 52-week high.
ICEL: 16.55 (+0.03)
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of CELLULAR DYNAMICS INTERNATIONAL, INC. of Commencement of an Investigation Concerning the Fairness of the Sale of the Company to FUJIFILM HOLDINGS CORPORATION -- ICEL
PR Newswire - Tue Mar 31, 8:57AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
ICEL: 16.55 (+0.03)
US university, foundation invested in frozen Chinese stocks
By JEFF HORWITZ - AP - Mon Mar 30, 4:14PM CDT
WASHINGTON (AP) — The University of Michigan, defense contractor Lockheed Martin Corp. and a foundation helping Appalachian children all own stakes in an overseas investment fund backing two major Chinese companies, which recently froze their stocks and missed financial reporting deadlines.
LMT: 213.26 (-1.11), MS: 32.72 (-0.27)
IPO Stock Watch: Fujifilm Acquiring Cellular Dynamics
at Investor's Business Daily - Mon Mar 30, 3:46PM CDT
Small biotech Cellular Dynamics (ICEL) more than doubled in heavy trading Monday to close at 16.42 on news that it is being acquired. Japanese giant Fujifilm (FUJIY), a photography gearmaker that branched into biotech, agreed to pay $307 million in...
ICEL: 16.55 (+0.03), ASPX: 100.96 (unch), TEVA: 58.96 (-0.28), CNCE: 20.87 (+0.62)
Stocks Roll Out Healthy Start; JPMorgan, Apple, Gentherm Climb
at Investor's Business Daily - Mon Mar 30, 9:34AM CDT
The stock market today rolled into the holiday-shortened week and Tuesday's end of the first quarter on healthy footing. JPMorgan Chase (JPM) muscled up 3% and Apple (AAPL) rose nearly 2%, helping hoist the Dow Jones industrial average 1.4% in early...
ABT: 41.89 (+0.73), CTRX: 61.47 (+0.04), UNH: 119.27 (+3.19), ALTR: 52.49 (+0.77), MYL: 42.55 (-0.12), ASPX: 100.96 (unch), HRZN: 10.01 (+0.03), THRM: 48.68 (+1.19), HPTX: 45.99 (+0.02), ICEL: 16.55 (+0.03), JPM: 61.93 (-0.20), ADI: 56.69 (-1.03), TEVA: 58.96 (-0.28), AAPL: 112.12 (+2.62)
Healthcare IT Market in UAE 2015-2019 - The Analysts Forecast the Market in UAE to Grow at a CAGR of 11.12% During 2014-2019
M2 - Wed Aug 19, 8:42AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hgmn7v/healthcare_it) has announced the addition of the "Healthcare IT Market in UAE 2015-2019" report to their offering. The analysts forecast the healthcare IT market in UAE to grow at a CAGR of 11.12% during 2014-2019. Covered in this Report This report covers the present scenario and the growth prospects of the healthcare IT market in UAE for 2015-2019. The market in UAE is categorized into three segments: hardware, software, and IT services. The report, Healthcare IT Market in UAE 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It covers the market landscape and its growth prospects in the coming years. The report also includes the profile of key vendors operating in this market. A major trend observed in this market is the adoption of patient registry software. Patient registry software is used to maintain a database for collecting secondary data related to patients. It provides timely and effective medical care by allowing physicians and staff to analyze patients' health, diagnosis, and treatment records. According to the report, the increasing government support for healthcare IT systems in this region is a driver that promotes growth in this market. Government initiatives and efforts to manage and streamline healthcare systems through IT have led to increased demand for IT products and services in the healthcare sector. Key Vendors - Cerner - GE Healthcare - HP - IBM - OCSHI - Siemen Other Prominent Vendors - Accenture - Agfa-Gevaert - Anglo Arabian Healthcare - Atos Healthcare - Balaxi Healthcare - Carestream Health - CGM - Ciber - Cisco Systems - Cognizant - CSC - Datasel Healthcare IT Solutions FZ - Eclinicalworks - FUJIFILM Holdings - Harris - Heathland - iSoft - Microsoft - Netcetera - Nuviun - Philips Healthcare - Sunquest Information Systems - Wipro Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Market Segmentation by Category 08. Buying Criteria 09. Market Growth Drivers 10. Drivers and their Impact 11. Market Challenges 12. Impact of Drivers and Challenges 13. Market Trends 14. Trends and their Impact 15. Vendor Landscape 16. Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/hg...lthcare_it
WIT: 12.80 (+0.22), IBM: 152.39 (+0.11), CERN: 64.08 (+0.66)
When Others Try to Disrupt, They Adjust
at The Street - Fri Aug 07, 2:30PM CDT
Some companies have been able to survive and thrive in new environments.
PBI: 20.81 (-0.04), KODK: 16.33 (-0.12), BBRY: 7.41 (+0.12), MSFT: 47.11 (-0.34), FLWS: 9.89 (-0.21), AAPL: 112.12 (+2.62), NOK: 6.98 (-0.06)
Fujifilm (FUJIY) Reports Strong Q1; Earnings Improve Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jul 31, 9:54AM CDT
Premium photographic image-product company Fujifilm Holdings Corporation (FUJIY) reported strong first-quarter fiscal 2016 (ended Jun 30, 2015) results.
ANY: 3.05 (-0.16), CRUS: 28.84 (-0.42), MLNX: 44.19 (+0.14)
Fujifilm (FUJIY) Retains Scope for Growth Despite Risks - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 13, 3:10PM CDT
We have issued an updated research report on the premium multinational company FUJIFILM Holdings Corporation (FUJIY) on Jul 10, 2015.
PLAB: 9.39 (-0.08), ANY: 3.05 (-0.16), ARMH: 43.99 (-0.22)
Global Market Study on Diagnostic Imaging Devices: Asia-Pacific to Witness Highest Growth by 2020
M2 - Wed Jul 08, 8:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2qh8mq/global_market) has announced the addition of the "Global Market Study on Diagnostic Imaging Devices: Asia-Pacific to Witness Highest Growth by 2020" report to their offering. The global diagnostic imaging devices market is anticipated to grow from an estimated USD 26,477.1 million in 2014 to USD 35,793.4 million in 2020 at a CAGR of 5.2% during the forecast period. Globally, the diagnostic imaging devices market is witnessing significant growth due to increasing prevalence of chronic diseases and injuries, and growing aging population. In addition, increasing funding from government bodies, rising initiatives undertaken by government associations to boost awareness, technological advancement and widening application of diagnostic imaging devices are also fueling the growth of the market. However, strict regulatory requirements and heightened risk of cancer owing to exposure to radiation restrain the growth of the global diagnostic imaging devices market. North America is the largest market for diagnostic imaging devices while X-rays are the most popular type of diagnostic imaging devices. In terms of growth, Asia is the fastest growing region; while nuclear imaging and computed tomography scanners make for the fastest growing type of diagnostic imaging devices. Ultrasound is a widely used imaging modality used for diagnosis, staging various diseases and to study internal body structures such as soft tissues and internal organs. The global ultrasound diagnostic imaging devices market was expected to grow from an estimated USD 6,146.7 million in 2014 to USD 8,363.4 million in 2020 at a CAGR of 5.3% during the forecast period. Key Topics Covered: Chapter 1 Preface Chapter 2 Market Synopsis Chapter 3 Porter's Five Forces Analysis Chapter 4 Industry Overview Chapter 5 Global Market Size and Forecast Chapter 6 Market Size and Forecast by X-rays Chapter 7 Market Size and Forecast by Ultrasound Chapter 8 Market Size and Forecast by Computed Tomography Chapter 9 Market Size and Forecast by Magnetic Resonance imaging Chapter 10 Market Size and Forecast by Nuclear Imaging Chapter 11 Market Size and Forecast by Geography Chapter 12 Competitive Scenario Chapter 13 Company Profiles - Carestream Health, Inc. - FUJIFILM Holdings Corporation - General Electric Company - Hitachi, Ltd. - Hologic, Inc. - Koninklijke Philips N.V. - Samsung Electronics Co., Ltd. - Shimadzu Corporation - Siemens Healthcare - Toshiba Corporation For more information visit http://www.researchandmarkets.com/research/2q...bal_market
GE: 28.07 (+0.04), HOLX: 37.28 (+0.08)
Europe Departmental Picture Archiving and Communication System Market by Product (Radiology PACS, Cardiology PACS, Others), by Deployment) & End User (Hospitals, Laboratories, Physicians) 2015-2019
M2 - Thu Jun 25, 8:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2v75f9/europe) has announced the addition of the "Europe Departmental Picture Archiving and Communication System (PACS) Market by Product, by Deployment, by End User And By Component - Analysis and Forecast to 2019" report to their offering. Europe represents the second largest market for Departmental PACS and in future it is expected to grow at a CAGR of 5.2% from 2014 to 2019. Germany commands the largest share of 25.1% of the European Departmental PACS, followed by France. Factors such as the growing trend of public healthcare systems and high price contracts, hospital consolidation, rising number of cardiology disorders, and technological advancements in cardiac monitoring facilities mainly drive the growth of the European Departmental PACS Market. However, factors such as creation of data silos, interoperability and hardware compatibility issues, expensive technology, and a compulsory need of professional assistance further limit the growth of this market. The report provides a DeepDive analysis of major market segments which include applications, deployment, component, types, end-users, and geography. The application segment comprises computed tomography, ultrasound, MRI, C-arms, digital radiography, nuclear imaging, and computed radiography. Deployments are divided on the basis of web-based, on-premise, and cloud based. Similarly, based on components, the market is classified into services, software, and hardware. The departmental PACS market is divided into two types-radiology and cardiology PACS. The key market players of the European Departmental PACS market include Agfa-Gevaert Group. (Belgium), Koninklijke Philips N.V. (Netherlands), Carestream Health (U.S.), FUJIFILM Holdings Corporation (Japan), McKesson Corporation (U.S.), General Electric Company (U.S.), and Siemens AG (Germany). For more information visit http://www.researchandmarkets.com/research/2v75f9/europe
GE: 28.07 (+0.04), MCK: 189.95 (+3.66)
The Global Flexible Endoscopes Market to Grow at a CAGR of 5.99% over the Period 2015-2019
M2 - Mon Jun 15, 4:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2s36m5/global_flexible) has announced the addition of the "Global Flexible Endoscopes Market 2015-2019" report to their offering. The report covers the present scenario and the growth prospects of the global flexible endoscopes market for the period 2015-2019. The market is divided into two segments: flexible videoscopes and flexible fiberscopes. Commenting on the report, an analyst from the research team said: Advances in technology have led to the development of innovative visualization technologies in endoscopes. Manufacturers are now offering a wide range of HD flexible endoscopes that provide high-quality images when used with compatible processors for better diagnosis of diseased organs or areas. HD images can now be combined with video systems that allow a more enhanced look at the mucosal surface of the organ. The system produces a light spectrum that recovers irregularities in the superficial mucosal surface that would not otherwise be detectable with standard white light. According to the report, as a person ages, the incidence of GI diseases such as colorectal and esophageal cancer, pancreatic, biliary, inflammatory bowel, and gastroesophageal reflux diseases, polyps, and other intestinal disorders increases. Many of these diseases are diagnosed or treated using endoscopy. The procedure is safe and effective, especially in elderly patients, and can be performed irrespective of age. Improved living conditions, the quality of healthcare, and advances in treatment options have led to a high demand for endoscopy in healthcare settings, which has increased the life expectancy of the aged. Companies Mentioned: - FUJIFILM Holdings - HOYA - Olympus Medical Systems - Cogentix Medical - KARL STORZ - MACHIDA Endoscope - Optim - Richard Wolf Medical Instruments - Stryker For more information visit http://www.researchandmarkets.com/research/2s...l_flexible About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CGNT: 1.28 (+0.03)
Event - Duodenoscope Panel Could Cut Olympus's Sales
EP Vantage - Seeking Alpha - Mon May 11, 10:45AM CDT
February’s outbreak of device-associated drug-resistant bacterial infections in the US did not prompt a product recall despite several patient deaths. Instead the FDA has responded- three months later- with an adcom, whose recommendations next...
Global Small Animal Imaging (In-Vivo) Market (Technology, Applications and Geography) - Industry Analysis and Forecast, 2013 - 2020
M2 - Fri May 08, 5:09AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w3lm7d/global_small) has announced the addition of the "Global Small Animal Imaging (In-Vivo) Market (Technology, Applications and Geography) - Industry Analysis and Forecast, 2013 - 2020" report to their offering. The market for small animal imaging (In-Vivo) is expected to reach at $2.1 billion by 2020 Rising number of Pharmaceutical companies and clinical research organizations, increasing applications of in-vivo imaging in pre-clinical research, real time data storage and high-resolution modalities, are the key growth factors of the market. Inadequate infrastructure provisions for research facilities, advanced instruments and the lack of skilled research personnel in emerging economies along with the requirement of high-end devices are likely to be the major restraints of small animal imaging (in-vivo) market. Going forward, the global clinical research initiatives, along with the development in technologies associated with pre-clinical trials will provide the platform for growth. North America, dominates the market amongst all geographies owing to adoption of advanced technologies, healthcare awareness and favorable reimbursement policies. Geographically, about -35 of the small animal imaging (in-vivo) market share is held by the North America owing to the heavy investments and affordability of advanced small animal in-vivo imaging devices in pre-clinical research. On the other hand, Asia-Pacific market would grow at the promising CAGR of 11.5% over the forecast period. Such high growth rate is majorly attributed towards untapped state of the market, hence would provide an opportunities for the small animal imaging devices manufacturers. Key Topics Covered: CHAPTER 1 INTRODUCTION CHAPTER 2 EXECUTIVE SUMMARY CHAPTER 3 MARKET OVERVIEW CHAPTER 4 GLOBAL SMALL ANIMAL IMAGING (IN VIVO) MARKET BY TECHNOLOGY CHAPTER 5 GLOBAL SMALL ANIMAL IMAGING (IN VIVO) MARKET BY APPLICATION CHAPTER 6 GLOBAL SMALL ANIMAL IMAGING (IN VIVO) MARKET BY GEOGRAPHY, 2013 2020, $MILLION CHAPTER 7 COMPANY PROFILES - Aspect Imaging Ltd. - Bruker Corporation - FUJIFILM Holdings Corporation - Life Technologies Corporation - Mediso Medical Imaging Systems - Miltenyi Biotech GmbH - PerkinElmer, Inc. - Promega Corporation - Siemens AG - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/w3...obal_small
LIFE: 11.59 (+0.04), PKI: 48.19 (+0.31)
Fujifilm Posts Improved Y/Y Q4 Results, Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue May 05, 10:40AM CDT
Share price of Fujifilm Holdings Corporation (FUJIY) rose 1.7% to close at $38.56 on May 4, 2015, after it reported fourth-quarter fiscal 2015 results on Apr 30.
ANY: 3.05 (-0.16), ALU: 3.74 (-0.04), ARMH: 43.99 (-0.22)
Successful Closure of the TOB for Cellular Dynamics International Inc., a Leading U.S. Company in the Development and Manufacture of iPSCs
Business Wire - Fri May 01, 5:31AM CDT
On April 3, 2015, FUJIFILM Holdings Corporation (President: Mr. Shigehiro Nakajima) (hereafter, "Fujifilm"
launched a tender offer bid (hereafter, "TOB" offering USD 16.50 per share for the issued and outstanding shares of common stock of Cellular Dynamics International, Inc., a leading company in the development and manufacture of iPS Cells (CEO: Robert Palay, Headquarters: Madison, Wisconsin, USA, NASDAQ listed, Securities code: ICEL) (hereafter, "CDI" . The TOB period expired on April 30, 2015 at 11:59 PM (U.S. Eastern Standard Time). The TOB is now successfully completed. On May 1, 2015 (U.S. Eastern Standard Time), following the completion of the necessary procedures, CDI will become a wholly-owned subsidiary of Fujifilm. WeissLaw LLP: The Cellular Dynamics International Acquisition by FUJIFILM Holdings Corporation Is the Subject of a Legal Investigation
PR Newswire - Fri Apr 03, 10:41AM CDT
The fairness of the proposed acquisition of Cellular Dynamics International ("ICEL" or the "Company"
by FUJIFILM Holdings Corporation ("FUJIFILM" is being investigated by WeissLaw LLP, a national class action, shareholder rights law firm. The investigation focuses on possible breaches of fiduciary duty and other violations of law by the Board of Directors of ICEL for agreeing to sell the Company to FUJIFILM. On March 30, 2015, the Company announced a definitive agreement for FUJIFILM to acquire ICEL in a transaction valued at approximately $307 million. Under the terms of the agreement, ICEL shareholders will receive $16.50 in cash for each ICEL share they own. ICEL: 16.55 (+0.03)
WeissLaw LLP: Cellular Dynamics International Acquisition By FUJIFILM Holdings Corporation May Not Be In The Best Interest of ICEL Shareholders
PR Newswire - Wed Apr 01, 12:05PM CDT
The fairness of the proposed acquisition of Cellular Dynamics International ("ICEL" or the "Company"
by FUJIFILM Holdings Corporation ("FUJIFILM" is being investigated by WeissLaw LLP, a national class action, shareholder rights law firm. The investigation focuses on possible breaches of fiduciary duty and other violations of law by the Board of Directors of ICEL for agreeing to sell the Company to FUJIFILM. On March 30, 2015, the Company announced a definitive agreement for FUJIFILM to acquire ICEL in a transaction valued at approximately $307 million. Under the terms of the agreement, ICEL shareholders will receive $16.50 in cash for each ICEL share they own. ICEL: 16.55 (+0.03)
Ryan & Maniskas, LLP Announces Investigation of Cellular Dynamics International, Inc.
PR Newswire - Wed Apr 01, 9:43AM CDT
Ryan & Maniskas, LLP is investigating potential claims against the board of directors of Cellular Dynamics International, Inc. ("Cellular Dynamics" or the "Company"
(NASDAQ: ICEL) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to FUJIFILM Holdings Corporation in a transaction valued at approximately $307 million. ICEL: 16.55 (+0.03)
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Cellular Dynamics International, Inc. - ICEL
PR Newswire - Tue Mar 31, 9:10PM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Cellular Dynamics International, Inc. ("Cellular Dynamics" or "the Company"
(Nasdaq: ICEL) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to FUJIFILM Holdings Corporation. ("FUJIFILM" . ICEL: 16.55 (+0.03)
CELLULAR DYNAMICS INTERNATIONAL, INC. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Merger with FUJIFILM Holdings Corporation
Business Wire - Tue Mar 31, 10:06AM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Cellular Dynamics International, Inc. ("Cellular Dynamics"
(NASDAQ: ICEL) concerning the merger with FUJIFILM Holdings Corporation. Under the terms of the agreement, valued at approximately $307 million, Cellular Dynamics shareholders will only receive $16.50 cash per share held, which is virtually no premium over the 52-week high. ICEL: 16.55 (+0.03)
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of CELLULAR DYNAMICS INTERNATIONAL, INC. of Commencement of an Investigation Concerning the Fairness of the Sale of the Company to FUJIFILM HOLDINGS CORPORATION -- ICEL
PR Newswire - Tue Mar 31, 8:57AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
ICEL: 16.55 (+0.03)
US university, foundation invested in frozen Chinese stocks
By JEFF HORWITZ - AP - Mon Mar 30, 4:14PM CDT
WASHINGTON (AP) — The University of Michigan, defense contractor Lockheed Martin Corp. and a foundation helping Appalachian children all own stakes in an overseas investment fund backing two major Chinese companies, which recently froze their stocks and missed financial reporting deadlines.
LMT: 213.26 (-1.11), MS: 32.72 (-0.27)
IPO Stock Watch: Fujifilm Acquiring Cellular Dynamics
at Investor's Business Daily - Mon Mar 30, 3:46PM CDT
Small biotech Cellular Dynamics (ICEL) more than doubled in heavy trading Monday to close at 16.42 on news that it is being acquired. Japanese giant Fujifilm (FUJIY), a photography gearmaker that branched into biotech, agreed to pay $307 million in...
ICEL: 16.55 (+0.03), ASPX: 100.96 (unch), TEVA: 58.96 (-0.28), CNCE: 20.87 (+0.62)
Stocks Roll Out Healthy Start; JPMorgan, Apple, Gentherm Climb
at Investor's Business Daily - Mon Mar 30, 9:34AM CDT
The stock market today rolled into the holiday-shortened week and Tuesday's end of the first quarter on healthy footing. JPMorgan Chase (JPM) muscled up 3% and Apple (AAPL) rose nearly 2%, helping hoist the Dow Jones industrial average 1.4% in early...
ABT: 41.89 (+0.73), CTRX: 61.47 (+0.04), UNH: 119.27 (+3.19), ALTR: 52.49 (+0.77), MYL: 42.55 (-0.12), ASPX: 100.96 (unch), HRZN: 10.01 (+0.03), THRM: 48.68 (+1.19), HPTX: 45.99 (+0.02), ICEL: 16.55 (+0.03), JPM: 61.93 (-0.20), ADI: 56.69 (-1.03), TEVA: 58.96 (-0.28), AAPL: 112.12 (+2.62)
